Senescent Cells & Senolytics _ Professor Judith Campisi Interview Series Ep2 - podcast episode cover

Senescent Cells & Senolytics _ Professor Judith Campisi Interview Series Ep2

Dec 08, 202110 minSeason 8Ep. 2
--:--
--:--
Download Metacast podcast app
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episode description

In this video Professor Campisi talks why we have senescent cells, a possible schedule for taking senolytics, and senescent cells and cancer.

The Campisi lab at the Buck Institute

https://www.buckinstitute.org/lab/campisi-lab/

Judith Campisi is a professor of biogerontology at the Buck Institute for Research on Aging. She is co-editor in chief of the Aging Journal, and founder of the pharmaceutical company Unity Biotechnology. Prof Campisi is widely recognized for her work on senescent cells and their influence on many manifestations of aging. Her laboratory discovered Senescence Associated Secretory Phenotype (SASP) and also discovered the first non-invasive biomarker to verify the efficacy of senolytics.

For the best experience, listen in Metacast app for iOS or Android